95% of the vets surveyed by the company reported success treating cats with Thyronorm Oral Solution for Cats, while 89% expected the liquid solution to improve compliance in the management of hyperthyroidism.
93% also said they found Thyronorm gave them an easier way to offer cats a low dose, or an 'in-between' dose, as it can be titrated 'to effect' – meaning the dose of treatment can be varied more easily to suit the individual animal.
Feline hyperthyroid specialist Dr Sarah Caney said she is unsurprised by the survey results: "Treatment is complex for cats needing a low dose, or an ‘in between’ dose, as standard anti-thyroid tablets are only available in a small number of dose sizes and are not designed to be split, halved or quartered. Also, if a cat is on alternating doses, it can be difficult for carers to remember which dose is due today."
Rachel Crowe, Norbrook’s Companion Animal Senior Product Manager, said: "We are delighted that overall 99% of the 200 veterinary surgeons surveyed would recommend Thyronorm in the management of hyperthyroidism, compared to other medical options."
Thyronorm contains 5mg/ml of thiamazole (methimazole). The initial starting dose is 5mg active ingredient per day, split into two doses.
Available in 30ml and 100ml bottles, with an in-use shelf life of six months, Thyronorm is available to order from all UK veterinary wholesalers.
The interactive checklist is designed to help practitioner and farmer to work closely together to draw up a workable action plan to improve youngstock health.
MSD Animal Health ruminant veterinary adviser Kat Baxter said: "This new checklist-based tool explores, records and scores calf health performance across five core areas to identify the strengths and weaknesses of any rearing unit’s environment and processes.
"Working through a series of 10 questions within each core area – designed to tease out where a rearing unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention. What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to monitor progress against agreed targets. Vets can also use the scores to benchmark their clients’ farms against each other."
Vets interested in using the new checklist-based tool on farm should contact their local MSD Animal Health account manager for further information.
The practice has also strengthened its surgery services with the appointment of Dr Delphine Holopherne-Doran, European Specialist in Veterinary Anaesthesia and Analgesia.
Ivan graduated from Bristol University in 1997. He worked in Hertfordshire before completing a surgical residency under the tutelage of Professor Peter Holt at Bristol University. Ivan has worked in referral centres in the UK and France. He is an RCVS Diplomate in Small Animal Soft Tissue Surgery and a Recognised Specialist in Small Animal Soft Tissue Surgery. Before joining Highcroft, he spent six years working as a senior staff surgeon at Bristol University.
Ed graduated from the Royal Veterinary College (RVC) in 1996. He worked in a mixed practice in Buckinghamshire before undertaking training positions at the RVC, University of Liverpool and the University of Cambridge. He passed the specialist Diploma examinations of the European College of Veterinary Surgeons in 2003. He has previously been a senior surgeon and member of academic staff at the University of Bristol and has worked in private referral practice.
Delphine graduated from Maisons-Alfort (Paris) Vet School in 1998. After working as an equine vet, where she developed an interest in veterinary anaesthesia and analgesia, she returned to vet school in Nantes where she ran the Anaesthesia department for 11 years. During this time, she gained a Master’s degree and a PhD in cardiovascular pharmacology and completed a residency, gaining European board certification in anaesthesia and analgesia, which led her to visit and train in universities around the world.
Highcroft Hospital Director Mr Chris Mayers said: “Ivan and Ed bring a wealth of experience in urinary tract surgery and, in particular, in urinary incontinence to Highcroft. The most common presentations are juvenile animals with ectopic ureters or urethral sphincter mechanism incompetence (post-spay incontinence). Ivan and Ed offer an innovative, minimally-invasive procedure using cystoscopically-guided laser ablation for patients with intramural ectopic ureters. Interventional radiology techniques are also a major interest for the team providing new, minimally-invasive solutions for intrahepatic shunts. The two surgeons have firmly adopted Subcutaneous Ureteral Bypass Systems (SUBS) in treating cats with ureteral obstruction, typically caused by calculi.
"Delphine adds world-class expertise in anaesthesia and analgesia and is already making a huge contribution to our hospital. With a high degree of skill in managing cardiovascular physiology and pharmacology cases, Delphine boosts our ability to support highly challenging and complex patients. Her knowledge of the use of local and region blocks for treating highly challenging pain cases and the anaesthesia of complex cardiovascular patients provides outstanding care for patients and promotes the highest standard in analgesia."
Highcroft Veterinary Group is based at 615 Wells Road, Whitchurch, Bristol and can be contacted on 01275 832410.
Sylvie, a four-month-old Maine Coon, was referred to NDSR with a loud heart murmur. Scans revealed she was suffering from a severe obstruction on the right side of her heart which was steadily becoming worse.
Her condition, double chambered right ventricle, is very rare and, until now, could only be corrected by open heart surgery. However, NDSR specialist cardiologist João Loureiro believed this would be too much of a risk for frail Sylvie, so he opted for a cutting balloon angioplasty which had never been applied to cats before because their hearts are so small.
He and fellow cardiology specialist Joel Silva carried out the procedure, which involved inserting two balloons on a wire into a vein in Sylvie’s neck and on to her heart. The first had four cutting blades, which were manipulated to score the obstruction before the second was gently inflated in order to relieve it. After the wire and balloons had been removed, the incision in Sylvie’s neck required just two stitches and within 48 hours she was well enough to return home.
A subsequent scan showed the level of obstruction had been reduced from severe to mild and her owner, Dr Bob Baxter, described her as “much more lively”.
João, who has a special interest in the treatment of congenital heart disease in small animals, said the decision to perform the interventional ballooning was made because of the risks of open heart surgery and the recent development of veterinary applications of the cutting balloon technique.
João said: "As Sylvie’s condition was so rare, wider application of the technique is limited in terms of the number of cats which could benefit from it. However, it is extremely relevant to those individuals who are affected and could be of use in the treatment of other, more common, conditions."
Joel said: "Cutting balloon angioplasty is routinely used in human medicine for treating narrowed and stiffened blood vessels and has recently been adapted to treat a heart condition in dogs but we believe this may be the first time it has been used to treat this condition in a cat."
The new law, which replaces the Data Protection Directive, come into effect from 25th May 2018. All businesses will be affected, including the veterinary profession, and failure to comply could result in heavy financial penalties. It is important, therefore, that all practices start to prepare for them and ensure that they will be compliant when the new legislation comes into play next year.
Renay Rickard, president of the VPMA said: "These new regulations concern how we will manage personal data, both that of our clients and our staff, and it’s imperative that we understand them and act on them. We arranged this webinar to inform our members, and were very lucky to have such a tailored presentation directly from the regulator – helped by the fact that Helen, the speaker, comes from a veterinary practice background. It was so useful, we felt that the wider veterinary community would benefit from listening to it, so we’re pleased to open it up to non-members."
The webinar content guides listeners through the key changes ahead and the steps that practices will need to take to ensure they are compliant with the new legal requirements. This includes the impact the changes will have on marketing strategies and practice positioning on sending client reminders (e.g. vaccination, appointment); sharing case histories; passing on data regarding 'bad-debtors', as well as how to approach 'tagging' clients records (for example, re debt) in compliance with the GDPR.
The webinar also provides useful information on where to turn if practices need help and advice, as well as what to do if a data breach is detected. Finally, a detailed questions and answers session covers the day-to-day scenarios in practice that involve handling or sharing client data.
The recording can be accessed on request by emailing the VPMA Secretariat, secretariat@vpma.co.uk.
Photo: GDPR - General Data Protection Regulation. data 25 may 2018. Map EU and flag. Shutterstock/a_Jarm
Christine will take over from Nigel Gibbens who is stepping down at the end of February 2018 after 10 years in the post.
Christine, who comes from a farming family in the south of Scotland, is an experienced veterinary surgeon who worked for a number of years in private practice in Scotland and the north of England, prior to joining the Animal Health agency (now part of the Animal and Plant Health Agency) in 2008 as a Divisional Veterinary Manager in Scotland.
Since 2016, she has been working as the CVO in New South Wales, Australia, where she has led major improvements to biosecurity across many farming sectors.
Christine said: "I am delighted to have been appointed and it will be a privilege to lead my veterinary colleagues to support our farming and food industry in this hugely important role.
"I am very much looking forward to working again with the team at Defra, its agencies, the devolved administrations and all the individuals and groups which will contribute to meet future challenges across animal health and welfare.
"The UK Government has made no secret it wants to cement its place as a world-leader on animal welfare as they leave the European Union, and I’m delighted to have an opportunity to play a part in that."
Nigel said: "I would like to congratulate Christine on her success against a strong field of candidates and I am certain she will be a great addition to the department.
"Her breadth of experience from work within Government and in the private sector will enable her to provide excellent veterinary leadership to the Defra group to deliver government’s ongoing commitment to maintaining our high animal health and welfare standards and to represent the interests of the whole of the UK internationally."
Animal Welfare Minister Lord Gardiner added: "I warmly welcome Christine to her important role. She brings to it a wealth of experience and enthusiasm.
"This Government is embarking on an ambitious programme of animal welfare reform, including plans to increase the maximum sentence for animal cruelty to five years in prison and introducing mandatory CCTV in all abattoirs. Christine will be invaluable in helping us in achieving world leading standards.
"I thank Nigel Gibbens for his outstanding contribution as CVO over the past ten years. Leaving the department at the end of February, he is hugely respected across the veterinary community and beyond – leading on responses to disease outbreaks including avian influenza and advising government on issues from antimicrobial resistance to animal welfare."
British Veterinary Association President John Fishwick said: "We’d like to congratulate Christine Middlemiss on her appointment as the UK’s next CVO and welcome her return to Defra - as well as to the UK, following her 16 months as CVO in New South Wales, Australia.
"As Christine notes, she will take up her role amidst EU Exit negotiations when the vital role veterinary surgeons play in so many areas of political and public life must be championed and considered more than ever.
"The work of all vets in government is indispensable in protecting and promoting animal health and welfare and public health, and current UK CVO Nigel Gibbens CBE has been crucial in steering this with calm direction and sage insight from the heart of government.
"We hope to continue our effective working relationship with the new UK CVO, and really look forward the opportunity to work with Christine moving forwards."
Christine will take up her new role as CVO for the UK on the 1 March 2018.
Redonyl Ultra contains essential fatty acids, Palmitoylethanolamide (PEA) and Biotin.
PEA is a naturally-occurring bio modulator which Dechra says has scientifically proven activity against the mechanisms that contribute to inflammation and pain, while Biotin is important for synthesis of fatty acids and support of optimal skin condition.
Dechra Brand Manager Claire Morgan said: "Redonyl Ultra is a great addition to Dechra’s extensive Dermatology range that allows an holistic approach to treatment, control and maintenance of dermatological conditions.
"Allergic skin conditions are among the most common causes of skin and ear disease in cats and dogs, and it is estimated that up to 15 per cent of dogs are affected by atopy. In situations where an allergen cannot be avoided, multi-modal therapy is useful to control the clinical signs."
Redonyl Ultra comes in a convenient bottle size of 60 skittle capsules, in two strengths for different sized animals. The capsules can be opened and given with food or ingested directly, or swallowed whole for flexible administration.
For more information, visit http://bit.ly/2iNa2Ik
The nomination period runs until 5pm on Tuesday 31 January 2018. In order to stand, candidates will need to submit a nomination form along with contact details, a short biography and a statement, and supply a high-resolution digital photograph.
Each candidate also needs two nominators, who should be veterinary surgeons who are on the College’s Register but are not current RCVS Council members.
Professor Stephen May, RCVS President, said: "I myself have been an elected Council member since 2012, and it has given me tremendous opportunity to get involved with a whole range of subjects, including my particular interests, undergraduate education and lifelong learning. It’s incredibly rewarding to see how the decisions you make during your time on Council can really benefit the profession, and I would encourage anyone who shares an interest in the future of our profession, whether that be about graduate outcomes, practice standards, the wider veterinary team or the effects of Brexit, for example, to stand for election."
Although the RCVS is planning the elections as usual, it is concurrently preparing for a change to its governance arrangements, including a reduction in the size of the Council, as agreed in March 2016.
Commenting on the Legislative Reform Order (LRO) that will be required to amend the Veterinary Surgeons Act 1966, RCVS Registrar Eleanor Ferguson said: "This is a complex matter and, unfortunately, due to unavoidable delays associated with the 2017 General Election and the impact of preparing for the UK’s departure from the European Union, the LRO has not yet completed the legislative process.
"This means that whilst we will be running the elections on the basis that there will be six elected places available, as per the old size and structure, it should be expected that under the new size and structure, only three places will ultimately be available."
Meanwhile, due to comparable changes to the governance of the Veterinary Nurses Council, including a reduction in its number, there will be no 2018 VN Council elections as the outgoing members will not need to be replaced.
The RCVS Council election period will start around mid-March and voting will close at 5pm on Friday 27 April 2018.
Nomination forms, guidance notes and frequently asked questions are available for prospective RCVS Council candidates at www.rcvs.org.uk/rcvscouncil18.
The milk withdrawal has been reduced from 108 hours to 96 hours and the dose is now 15 mg/kg for three consecutive days.
Kath Aplin, veterinary adviser for Boehringer Ingelheim Animal Health, said: "The new dosage regimen gives clearer guidance to vets and their clients; a 660kg cow should receive 10g of penethamate hydriodide (one vial) daily for three days.
Mamyzin, a lecithin coated pro-drug of benzyl penicillin, is highly lipophilic and actively concentrates in the udder, where it is capable of entering epithelial cells to achieve intracellular bacterial kill1. It provides targeted, narrow spectrum treatment for gram positive mastitis in situations where injectable therapy for mastitis is required."
Reference
Entries for the awards, which were presented at a ceremony held at Wembley Stadium, came from a wide range of SMEs employing less than 250 employees, operating across all industries.
This latest achievement comes at the end of a successful year for the company, which saw it celebrate 80 years in business and recruit its 200th team member after creating 50 new jobs in the last 12 months alone. Earlier this year, White Cross Vets was also included in The Sunday Times ‘Best 100 Small Companies To Work For’ league table for the fifth year running.
Tim Harrison, Managing Director of White Cross Vets, said: "To be named as the UK’s best SME is an amazing achievement and we’re extremely proud of it. We take immense pride in making White Cross Vets a superb place to work and always strive to foster a close-knit and highly motivated team.
"As part of this we’ve further enhanced the wide range of employee benefits that our people enjoy this year, which ultimately translates into the level of care and standard of service that our clients receive. Winning the ‘Employer of the Year’ award reinforces this and cements our position at the forefront of the veterinary industry."
Damian Cummins, Awards Director, said: "White Cross Vets is a very worthy winner from the best of businesses across the UK, a great achievement and ambassador for SME’s."
Employment initiatives that White Cross Vets offers include days off and cakes for birthdays, five donation days a year to volunteer with chosen charities and a health care scheme as well as subsidised Fitbits and gym memberships.
In short, it's a way for equine vets, researchers and students to stay on top of the latest research without accumulating towering stacks of unread journals.
Early reaction to the publication has been very positive. Professor Renate Weller at the Royal Veterinary College said: "HoofSearch is a great tool for anybody interested in staying up to date with what work is going on in relation to horse feet. It is a trustworthy source at an affordable price.
Renate added: "I am not the only one who appreciates HoofSearch; the farriers enrolled in our new degree in research are also using it for their work."
RVC Structure and Motion Laboratory PhD candidate Amy Barstow, BVetMed (Hons), agreed: "HoofSearch gives you a straightforward, time-efficient way to stay on top of the latest research."
Michigan State University College of Veterinary Medicine Professor Emerita Hilary M. Clayton also endorses the new publication. She said: "HoofSearch is worth its weight in gold – instead of spending countless hours scouring the literature, I just go through HoofSearch each month and find all the new publications, proceedings and patents neatly classified and enough of the abstract to convey the contents of the article."
Publisher Fran Jurga said: "Everywhere professionals are involved in helping horses with foot problems, the push is on to both be able to access and build on a comprehensive, if still evolving, body of knowledge. These reports will be useful to track how this newly expanding field of research grew and contributed to the improved welfare, longevity and soundness of horses in the future. I can’t wait to add more editions on other equine health subjects."
A subscription to HoofSearch is US$119, worldwide, for 12 editions.
For more information, visit: https://goo.gl/hJTISt
To subscribe (outside the US), visit: https://www.paypal.me/Hoofcare/119
Paragon is being built by the Linnaeus Group, which says the new centre will be one of the largest and best-equipped in the UK when it opens its doors early in the New Year.
The new centre follows the Linnaeus Group's acquisition of Dewsbury-based Calder Vets last year.
Calder Vets' existing referral teams, together with two ophthalmologists from its Mirfield branch, will be transferring to Paragon. Meanwhile, Calder Vets will move to solely first-opinion work.
Currently nearing the end of construction, the centre will have eight consulting rooms, five operating theatres, MRI and CT scanners, intensive care facilities along with an all-digital imaging department.
A total of up to 80 staff will be employed at Paragon, including up to 18 referral vets and 32 veterinary nurses.
Specialist services will include cardiology, neurology, ophthalmology and orthopaedic and soft tissue surgery.
Positions currently available include a diagnostic imager, internal medicine specialist, neurology specialist, oncology specialist and an ophthalmologist, as well as various nursing posts.
Ian Monteith, managing director of Paragon, said: "We are looking for the best possible people who not only have the right skills and experience, but who will also fit into the ethos we want to create at Paragon.
"It is a significant and exciting opportunity for motivated, high calibre people to help shape something that has a very bright future for both the industry and for their own careers.
"Our philosophy is very much one of friendly cooperation between all members of staff, creating a pleasant, supportive and good-humoured atmosphere."
For details of the vacancies currently on offer at Paragon, visit www.paragonreferrals.co.uk/en-GB/careers
Centaur will continue to operate its warehouse in Castle Cary, Somerset; the new facility will allow the company to bolster its services to customers throughout Northern England, North Wales and Scotland.
AmerisourceBergen says the new Midlands facility will hold more than 13,000 products and be licensed for the wholesale distribution of veterinary and human medicines. The facility will use a state-of-the-art warehouse management software to provide efficient and accurate order fulfillment and improve the visibility of products in the supply chain.
Brian Topper, Managing Director of AmerisourceBergen Animal Health U.K. said: "Our expanded presence and capabilities in the U.K. is a reflection of the demand for high-quality solutions, and we’re growing to best meet our customers’ needs.
"Practices of all sizes rely on us to provide them with timely access to the products they need on a daily basis. With broader scope and capacity, we’ll be able to go beyond our best-in-class services and provide an unmatched customer experience by delivering critical products to practices in a more efficient and consistent manner than ever before."
The company says that the new warehouse will create more capacity at its Somerset warehouse and put the company in a positive inventory position to buffer against any business continuity challenges that may occur – ensuring that practices and their patients continue to have access to vital products.
Lisa Derbyshire, Director of Operations & Supply Chain at Centaur Services said: "As the industry moves forward, we want to ensure our customers have access to high-quality infrastructure that maximizes product safety and improves operational efficiency. Adding critical resources and upgraded service offerings, like our new distribution center in the Midlands, enables us to be at the forefront of distribution while continuing to provide the excellent service that our customers have come to know and expect from Centaur."
The new bill - Animal Welfare (Sentencing and Recognition of Sentience) - would increase the maximum prison sentence for animal cruelty tenfold, from six months to five years, in England and Wales.
The draft bill also sets out that the government "must have regard to the welfare needs of animals as sentient beings in formulating and implementing government policy".
Subject to consultation on the draft bill, the government says it will legislate to deliver both aims.
In fact, the draft bill goes further than Article 13 as it applies to all areas of government policy, rather than specified areas of policy. If passed, the law would apply to the whole of the UK.
Environment Secretary Michael Gove said: "Animals are sentient beings who feel pain and suffering, so we are writing that principle into law and ensuring that we protect their welfare. Our plans will also increase sentences for those who commit the most heinous acts of animal cruelty to five years in jail. We are a nation of animal lovers so we will make Brexit work not just for citizens but for the animals we love and cherish too."
BVA President John Fishwick said: "Vets have been clear in our calls that the duty on the state to have due regard for animal welfare - as captured in Article 13 of the EU Lisbon Treaty - must be enshrined in UK law. This Bill captures the substantive obligation that Article 13 currently puts on the national government to consider animal welfare, as well as explicitly recognising animals as sentient beings."
"Today’s draft Bill lays out in black and white the Government making good on its promises, to ensure the UK remains a global leader in animal welfare post-Brexit."
The RCVS Disciplinary Committee heard two charges against Dr Nemes, the first being that he had posted comments on social media about another veterinary surgeon, his employer, Dr Toth, which were offensive and/or derogatory and/or inappropriate.
The second charge was that Dr Nemes had posted his comments without having sufficient regard to maintaining their confidentiality and/or privacy.
Dr Nemes admitted the charges, though he did inform the Committee that his admission with respect to the second charge was caveated by the proposition that the comments were posted in private messages on Facebook with a limited membership, namely employees of Healers Veterinary Centre (Dr Toth’s practice).
The Committee noted the Respondent’s admissions as to the charges raised against him and pronounced the facts found proved.
In relation to the first charge, the Committee found that the comments on social media were, without a doubt, highly unprofessional. They included offensive language, were gratuitously personal against Dr Toth, and were made within an online chat which included junior lay staff, all employed by Dr Toth.
This behaviour was seen to directly contravene a numbers of parts of the RCVS Code of Professional Conduct, in particular Paragraph 5.3 that states: "Veterinary Surgeons and Veterinary Nurses should not speak or write disparagingly about another Veterinary Surgeon or Veterinary Nurse."
In relation to the second charge, the Committee found that Dr Nemes had paid no regard to maintaining the confidentiality and/or privacy of his malicious and damaging entries to the chat.
At the outset of his evidence, Dr Nemes admitted that the proven charges amounted to serious professional misconduct. The Committee noted however that the question of whether he was guilty of serious professional misconduct or not was in fact a matter for it to decide, notwithstanding his admission.
The Committee considered the fact that the period of time that Dr Nemes was involved in making postings was effectively about two weeks, that his involvement followed his wife’s dismissal from employment (representing a breach of Dr Nemes’ resignation conditions), and that he was very stressed at the time.
It also considered Dr Nemes’ point that he had never anticipated that Dr Toth would see the Facebook Messenger conversation, and that the relevant RCVS supporting guidance to the Code concerning good practice when using social media and online networking forums was only published in late November 2014 when Dr Nemes’ involvement in the conversation was virtually at an end.
In summing up, Ian Green, Chair of the Committee, said: "The Committee carefully considered the circumstances surrounding the Facebook Messenger entries which the Respondent posted from 13 November 2014. It noted that at the time he had handed in his resignation, morale at the practice was very low. The Facebook Messenger chat site had been started amongst the receptionist/animal carers. A perusal of the entries before the Respondent joined on 13 November 2014 demonstrates that morale was low among that group.
"…Notwithstanding the nature of the remarks posted on the Facebook Messenger, which the Committee deplores, it has reached the conclusion that, whilst the Respondent’s behaviour amounts to misconduct and falls short of the standards expected of a member of the veterinary profession, it does not amount to serious misconduct and does not fall far short.
"In the circumstances it has reached the unusual conclusion that, notwithstanding the Respondent’s admission, the appropriate finding is that he is not guilty of disgraceful conduct in a professional respect."
The practical, wet lab, small group and 'Breakfast with a Specialist' programme has expanded to enhance the CPD experience and to meet rising demand, alongside more than 450 lectures for delegates to choose from.
Wet lab sessions, introduced at Congress 2017, will again be held at the University of Birmingham’s Medical School and include topics on cytology, haematology, basic eye surgery, rabbit dentistry and dental radiography for dogs and cats.
'Breakfast with a Specialist' sessions give delegates exclusive access to world-renowned experts to discuss challenging cases informally, in a small group setting: endocrinology cases with David Church on Friday, epilepsy cases with Holger Volk on Saturday and jaw fracture fixation in the dog and cat with Peter Southerden on Sunday.
BSAVA Congress Programme Committee Chair Sue Murphy said: "Responding to the excellent delegate feedback from 2017’s programme, we are increasing the number of practical and small group sessions to enable more delegates to benefit in 2018. These sessions represent excellent, value for money education and a unique opportunity for delegates to practice vital skills with guidance from experts in their respective disciplines.’"
Each workshop or small group is available to purchase when registering for Congress and a full summary of each practical and small group session is available at: http://www.bsavacongress.com/programme
The 61st annual BSAVA Congress takes place at the Birmingham ICC and Arena Birmingham from 5-8 April, including a new non-clinical stream on Sunday – Beyond the Clinics.
The BVA officer team consists of BVA President, Senior Vice President (SVP) and Junior Vice President (JVP).
BVA Officers collectively, and working closely with the Chief Executive and his team, provide leadership to BVA to help ensure the Association fulfils its mission to be the leading body representing, supporting and championing BVA members and the whole UK veterinary profession.
The BVA says it's looking for applications for the next JVP (2018/2019), becoming BVA President in 2019/20, from BVA members:
Nominations for the next JVP are confidential and will be assessed by the BVA Electoral College, which assesses nominations and formally selects members for election to BVA officer status.
Each officer role (JVP, President, SVP) is for one-year term from BVA’s Annual General Meeting (AGM) in September to the AGM the following September.
Candidates for JVP and President must be elected by the membership at the AGM to serve the coming year. The total commitment is therefore three years as a BVA officer, plus a further three years serving as a past president on BVA Council (four meetings per year).
BVA President John Fishwick said: "As a BVA officer, it is a huge honour to represent the UK’s veterinary profession however it is not simply an ‘honorary role’, particularly during this time of professional, social and political upheaval when BVA is supporting and championing the vital role vets play more than ever before.
"I have been a BVA officer for 15 months now and it is a privilege to be so involved in a profession that is pivotal to animal health and welfare, and public health too. Part of the role is representing the views of our profession clearly and concisely to policymakers, politicians and the media and, although this may seem daunting, you have the full support of the BVA team and are given invaluable training. I would encourage anyone with a passion to promote the value of the veterinary profession, and who is seeking a fulfilling role, to apply to help ensure BVA continues to be a strong voice for our profession."
BVA members who are interested in applying for, or nominating a fellow BVA member with their consent to become part of the BVA officer team, can apply before 9am on 15 January 2018 at www.bva.co.uk/elections
The website now contains a range of information on Alfaxan including user experiences, sections on best practice anaesthesia, webinars and details of Jurox’s anaesthesia roadshows.
The webinars include a presentation which explains how to use Alfaxan to achieve the best anaesthetic experience for the patient. There is also series of short online webinars on rabbit anaesthesia:
An online CPD certificate will be issued to veterinary professionals who have viewed each webinar, after they have taken a short online questionnaire.
The Alfaxan website also offers downloadable resources such as the new Considerations for Anaesthetising Rabbits expert panel guidelines booklet, AVA Anaesthetic Safety Checklist Implemenation manual, AVA Anaesthetic Safety Checklist and Alfaxan resource guides, user guides, dose charts and monitoring charts.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Our new Alfaxan website is an educational hub that enables veterinary professionals to learn more about best practice anaesthesia and how this can be implemented in their own clinics. With Alfaxan’s new pet rabbit indication we have included an emphasis on rabbit anaesthesia and how this differs from anaesthesia in cats and dogs."
For further information, visit www.alfaxan.co.uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
A graduate of University College Dublin, Richard started out in first opinion practice after completing an internship at the University of Glasgow.
While studying medicine, Richard researched mast cell tumours in dogs, which led to an MSc in clinical Oncology. He went on to complete a PhD on mast cell tumours at the Royal Veterinary College in 2008.
Richard works with referral oncology patients and clients two days a week at LVS and currently spends the rest of his working week as an oncology consultant for IDEXX Laboratories.
From February, Richard will also be working at Southfield Veterinary Specialists in Laindon, Essex, thereby allowing him to refer oncology patients for radiation therapy at Southfields when necessary.
Richard said: "Having never been comfortable with operating myself, working with a team of this calibre and experience in a welcoming environment within central London was very attractive. It has been a very fulfilling role for me, especially as both our team and the scope of the services we can offer continue to expand.
"Given the high standard of care offered by local vets in the area, the patients referred to LVS are often very challenging. Together with our clients’ high expectations, the service is definitely not run-of-the-mill but all the more rewarding because of that.
"I’m looking forward to bringing my experience in both research and clinical spheres to LVS."
Richard’s main professional interests are mast cell tumours, novel diagnostics and immunotherapeutics, but he is experienced in all aspects of veterinary oncology and can also offer advice about internal medicine cases.
Despite the fact that homeopathic preparations are supposed to be diluted to the point where none of the original ingredient remains, the FDA says it has received increasing reports of products containing distinctly unhomeopathic quantities of things like belladonna being associated with serious adverse events.
The FDA has also had to issue warnings about homeopathic zinc-containing intranasal products which may cause a loss of the sense of smell and other homeopathic remedies which contain potentially toxic ingredients, such as nux vomica, which contains strychnine.
However, it is not just products with safety concerns that the new proposals are designed to address. Following in the footsteps of the NHS, the Australian National Health and Medical Research Council, The House of Commons Science and Technology Committee and more recently, the Royal College of Veterinary Surgeons and the European Academies Science Advisory Council (EASAC), the new FDA proposals highlight the risk from homeopathic remedies being marketed for serious diseases or conditions when they have not been shown to offer clinical benefits.
The proposals also highlight the risk to vulnerable populations that: "may also be at greater risk of harm as a result of foregoing the use of medical treatments that have been found safe and effective."
FDA Commissioner Scott Gottlieb, M.D. said: "In recent years, we’ve seen a large uptick in products labeled as homeopathic that are being marketed for a wide array of diseases and conditions, from the common cold to cancer.
"In many cases, people may be placing their trust and money in therapies that may bring little to no benefit in combating serious ailments, or worse – that may cause significant and even irreparable harm because the products are poorly manufactured, or contain active ingredients that aren’t adequately tested or disclosed to patients.
"Our approach to regulating homeopathic drugs must evolve to reflect the current complexity of the market, by taking a more risk-based approach to enforcement. We respect that some individuals want to use alternative treatments, but the FDA has a responsibility to protect the public from products that may not deliver any benefit and have the potential to cause harm."
VetSurgeon.org supports the Campaign for Rational Veterinary Medicine.
Photo: Multicolored homeopathy tubes isolated on a white background. Lush. Shutterstock.
The Horse Trust provides a range of services to support working horses, while Medical Detection Dogs trains dogs to alert their owners to cancers and other medical conditions, providing pre-emptive non-invasive warning.
Stephen said: "These two charities' work in strengthening and supporting the human-animal bond is truly remarkable. Though The Horse Trust was originally founded in 1886 as a retirement home for working horses, and this remains a core focus of theirs to this day, it has now evolved to provide a whole range of services, from education to research to rescuing neglected equids.
"Medical Detection Dogs, though founded much more recently in 2008, has already done an incredible amount in its short history - 76 of its dogs are now partnered with people with critical medical conditions, ensuring essential emotional as well as medical support."
Jeanette Allen, CEO of The Horse Trust, said: "The Horse Trust is extremely grateful to the RCVS for this enormously generous donation. We care for 130 horses, ponies and donkeys that have either retired from public service or been rescued from appalling conditions. We also provide dedicated training programmes for first responders who have to deal with horses in crisis situations, as well as being the second largest funder of equine specific veterinary research in the UK. We survive as a charity on donations, and this one is most welcome and greatly appreciated."
Claire Guest, co-founder and chief executive of Medical Detection Dogs, said: "We are so grateful to the RCVS for their very generous donation. We receive no government funding for our work, so we rely entirely on the generosity of organisations like the RCVS. Thanks to this donation, we can continue our pioneering research into the detection of human disease using the extraordinary smelling power of dogs."
The President’s Christmas Box donation is made every year in lieu of sending out RCVS Christmas cards. Previous recipients have included Worldwide Veterinary Service, Mind, Riding for the Disabled Association, Canine Partners, Hounds for Heroes, and Vetlife.
Dechra Brand Manager Craig Sankey said: "It can be a very worrying time for owners if their pet is being investigated for, or diagnosed with, hypothyroidism and the new website aims to help them understand more about the condition, how it manifests itself and what they can expect on the management journey.
"Effective management of the condition can significantly improve a dog’s quality of life and prevents the development of other, potentially life-threatening conditions, for which treatment can be intensive and costly."
The website also has a Frequently Asked Questions section and an interactive log book for owners to fill in which can also be emailed to their veterinary surgeon to assist in tracking the dogs’ progress and ensure that treatment is at its optimal level.
For more information, visit www.hypothyroiddog.com
IMV says it has acquired BCF to widen its offering in the reproduction management sector, particularly in imaging. As part of this strategy the company acquired ECM, a French veterinary ultrasound manufacturer, last June, and has launched AlphaVision, a video-assisted bovine insemination system.
Alan Picken, Managing Director of BCF, will lead the imaging division of IMV Technologies and become a member of the Management Board of the Group.
Philippe Gravier, Chief Executive Officer of IMV Technologies, said: "For over 50 years, IMV has been at the forefront of innovations in animal artificial insemination and embryo transfer. Following the acquisition of ECM earlier this year, the integration of BCF supports our vision to supply health status and reproduction-readiness tools to veterinarians, breeding technicians and livestock owners.
"I am very excited that BCF is joining the IMV Technologies Group. Our 100 employees have worked hard to build this company to where it is now. There is no doubt that IMV’s strong brand, customer loyalty and extensive distribution network will help to expand further our imaging activities. Like IMV, I share the vision that market differentiation is in supporting customers to improve animal care, achieved through constant innovation and marketing leading products and services."
The two best research projects were selected on the awards day with Sara Hillyer from the University of Bristol School of Veterinary Sciences winning the £1,000 top prize for her project on vascular endothelial glycocalyx shedding in clinical disease in cats and dogs.
Nicola Mawson from the Royal (Dick) School of Veterinary Studies won the £500 runner-up prize for her project on feline tooth resorptive lesions.
The other four successful candidates were Emily Clark from the University of Nottingham School of Veterinary Medicine & Science, Luca Fortuna from the Royal Veterinary College London, Jessica Lam from the Royal (Dick) School of Veterinary Studies, and Xaquin Castro Dopico from the Royal (Dick) School of Veterinary Studies. Each were awarded £1000 towards their research.
Michelle Townley, Veterinary Advisor and Bursary Co-ordinator at MSD Animal Health said: "We were delighted that we had so many applications this year and again the standard of research and presentation was extremely high. The winning students presented on a very wide range of research areas and selecting just two winners proved extremely hard. It is very encouraging to see such enthusiasm for research in the vets of the future."
Applicants were judged on the quality and clarity of their research project, and their ability to clearly communicate their conclusions.
Applications for the MSD Animal Health Veterinary Student Research Bursary 2018 will be opened early next year. For further information, visit: www.msd-animal-health.co.uk/company-overview/student-research-bursary.aspx
Sponsored by Boehringer Ingelheim, the Practice Marketing Award is free to enter, and open only to veterinary practices.
Entries need to demonstrate initiative and/or innovation in the marketing of the practice's services and/or products to clients or the general public during 2017. Eligible entries for the award can include: display advertising, direct mail or electronic media, such as email or websites.
VMA Awards Chair Claire Edmunds said: "Practices have often done a much better job of marketing than they think! And even if they don’t win, entering is great experience and the awards event provides an opportunity to network in the profession. As marketing is becoming an ever more important component in practice success, we would like to encourage as many practices as possible to enter the award."
Last year’s winner Vicky Scutt, joint owner and senior vet at Whitstable Bay Veterinary Centre, said: "Winning the Practice Marketing Award is a real highlight of my career so far! Receiving such a prestigious national award for our practice marketing proves the importance of staying true to your beliefs in business. It gave us the confidence to keep to the same message - because it's clearly working!"
The deadline for submissions is of 2nd February 2018, and the awards are presented on 16th March 2018 in the newly refurbished 5-star Royal Lancaster London hotel.
To enter the Practice Marketing Award, visit: https://www.vma.org.uk/vma-award-categories/practice-marketing-award-entry/
To book event tickets, visit: http://www.vma.org.uk/events/vma-annual-advertising-awards/
For any other information, visit: www.vma.org.uk, email: secretary@vma.org.uk or telephone 0330 223 2259.